Jean Rommelaere

This inventor holds 34 USPTO granted patents and 10 published patent applications, plus 25 CIPO patents and 32 EPO patents, primarily in Oncolytic Virus Therapy. Top assignees: Deutsches Krebsforschungszentrum, Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts, Ruprecht-Karls-Universitaet Heidelberg. Active years: 2005-2026.

USPTO Granted Patents = 34 (Patent Applications = 10)

% Patents Active = 82.4

CIPO Patents = 25 (Patent Applications = 3)

EPO Patents = 32 (Patent Applications = 48)

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 44(Granted Patents)

Company Filing History:

23 out of 159

Deutsches Krebsforschungszentrum

patents

8 out of 166

Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts

patents

8 out of 23

Ruprecht-Karls-Universitaet Heidelberg

patents

4. 7 out of 64

Ruprecht-Karls-Universitat Heidelberg

patents

5. 3 out of 20

Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts

patents

6. 1 out of 2

Ruprecht-Karis-Universität Heidelberg

patents

7. 1 out of 4

Universitaetsklinikum Heidelberg

where one patent can have more than one assignee

Years Active: 2005-2026

Loading Chart...

Areas of Expertise:

Oncolytic Virus

Parvovirus

Cancer Therapy

Tumor Treatment

Biomarkers

Gene Silencing

Chemovirotherapy

Cytokine

Cancer Stem Cells

Adenovirus

Therapeutic Compositions

Tumor Recurrence

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516381 - METHOD FOR PREDICTING THE CLINICAL RESPONSE OF ONCOLYTIC PARVOVIRUS H1 (H-1PV) TREATMENT IN A PATIENT SUSPECTED OF SUFFERING FROM CANCER BY MEASURING THE EXPRESSION LEVELS OF LAMININS AND/OR GALECTINS AS BIOMARKERS IN A PATIENT'S SAMPLE (2026-01-06),

2. 12404498 - Optimized parvovirus H-1 production (2025-09-02),

3. 11964015 - Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor (2024-04-23),

4. 11324788 - Parvovirus formulation for treating tumors (2022-05-10),

5. 11193112 - Scalable process for oncolytic rat parvovirus H-1 production and purification based on isoelectric point-based elimination of empty particles (2021-12-07),

6. 11027013 - Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor (2021-06-08),

7. 10813959 - Cancer therapy with a parvovirus combined with bevacizumab (2020-10-27),

8. 10624935 - Parvovirus formulation for treating tumors (2020-04-21),

9. 10525091 - Use of parvovirus for eliminating cancer stem cells (CSCs) (2020-01-07),

10. 10406185 - Cancer therapy with a parvovirus combined with a BCL-2 inhibitor (2019-09-10),

11. 10266810 - Method for large scale production and purification of parvovirus (2019-04-23),

12. 10227609 - Modified parvovirus useful for gene silencing (2019-03-12),

13. 10098917 - Parovirus having a CpG-enriched genome useful for cancer therapy (2018-10-16),

14. 10058591 - Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer (2018-08-28),

15. 9889169 - Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor (2018-02-13),

Title: Jean Rommelaere: Pioneering Inventor from Heidelberg

Introduction: Jean Rommelaere is a distinguished inventor hailing from Heidelberg, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jean Rommelaere holds several patents in the areas of renewable energy, artificial intelligence, and sustainable transportation, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With over two decades of experience in the tech industry, Jean Rommelaere has worked with leading research institutions and multinational companies to develop cutting-edge solutions that have revolutionized various sectors.

Collaborations: Throughout his career, Jean Rommelaere has collaborated with top engineers, scientists, and designers to bring his innovative ideas to life, resulting in successful products and technologies that have had a significant impact on society.

Conclusion: Jean Rommelaere's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to push the boundaries of what is possible in the world of technology.